Karen Lightning-Jones, Integrated Franchise Leader at Roche Pipeline, speaks to pharmaphorum’s Linda Banks in Deep Dive: Digital II about how the company is applying data management and digital tools in the real world, and advancing genomic testing to improve treatment and outcomes in cancer.
From humanising a brand and generating trust to providing meaningful interactions with private professional communities, live video offers many benefits to pharma companies.
Richard Staines gives a round-up of the latest developments in digital health.
Jay Bradner, head of Novartis’ drug discovery, talks to pharmaphorum about the firm’s drive to transform itself into ‘a medicine and data science company’.
Vanessa dos Reis Ferreira is head of Patient Advocacy Europe at Santhera and a rare disease specialist. Here she describes how her company is focused on understanding patient needs to develop and bring to market the best possible medicines.
John Grumitt, vice president of Diabetes UK and chief executive of Changing Health, says digital health innovators can work with big pharma to address medical needs.
Are you prepared for the upcoming changeover to the new EU risk management plan (RMP) template? Seema Jaitly offers some timely guidance on the new EU RMP document.
The decline in numbers of healthcare professionals (HCPs) willing to contribute to market research could have a detrimental effect on the quality of data provided to pharma. John Aitchison reports on why fewer are willing to join in and offers five changes that need to be made to improve uptake.